Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Recruiting

Phase 3

Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Sponsor:

ACADIA Pharmaceuticals Inc.

Code:

NCT06173531

Conditions

Hyperphagia in Prader-Willi Syndrome

Eligibility Criteria

Sex: All

Age: 5 - 30

Healthy Volunteers: Not accepted

Interventions

Carbetocin

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information